Atlas Trials

Genotype-driven Phase I Study of Irinotecan Administered in Neoadjuvant Chemoradiotherapy in Patients With Stage II/III Rectal Cancer

Clinical trial NCT01474187 · UNKNOWN

Trial details

NCT number
NCT01474187
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2011-11-01
Primary completion
2011-11-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.